CD146/sCD146 in the Pathogenesis and Monitoring of Angiogenic and Inflammatory Diseases.
Xavier HeimAhmad JoshkonJulien BermudezRichard BachelierClea DubrouJosé BoucrautAlexandrine Foucault-BertaudAurélie S LeroyerFrancoise Dignat-GeorgeMarcel Blot-ChabaudNathalie BardinPublished in: Biomedicines (2020)
CD146 is a cell adhesion molecule expressed on endothelial cells, as well as on other cells such as mesenchymal stem cells and Th17 lymphocytes. This protein also exists in a soluble form, whereby it can be detected in biological fluids, including the serum or the cerebrospinal fluid (CSF). Some studies have highlighted the significance of CD146 and its soluble form in angiogenesis and inflammation, having been shown to contribute to the pathogenesis of many inflammatory autoimmune diseases, such as systemic sclerosis, mellitus diabetes, rheumatoid arthritis, inflammatory bowel diseases, and multiple sclerosis. In this review, we will focus on how CD146 and sCD146 contribute to the pathogenesis of the aforementioned autoimmune diseases and discuss the relevance of considering it as a biomarker in these pathologies.
Keyphrases
- systemic sclerosis
- endothelial cells
- multiple sclerosis
- interstitial lung disease
- cerebrospinal fluid
- oxidative stress
- mesenchymal stem cells
- rheumatoid arthritis
- cell adhesion
- induced apoptosis
- type diabetes
- nk cells
- cardiovascular disease
- adipose tissue
- amino acid
- endoplasmic reticulum stress
- vascular endothelial growth factor
- peripheral blood
- protein protein
- weight loss